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Purpose: To investigate associations between neuroimaging markers 
of cerebrovascular disease, including lesion topography 
and extent and severity of strategic and global cerebral tis-
sue injury, and cognition in carotid artery disease (CAD).
Materials and 
Methods:
All participants gave written informed consent to undergo 
brain magnetic resonance imaging and the Addenbrooke’s 
Cognitive Examination–Revised. One hundred eight pa-
tients with symptomatic CAD but no dementia were in-
cluded, and a score less than 82 represented cognitive im-
pairment. Group comparison and interrelations between 
global cognitive and fluency performance, lesion topogra-
phy, and ultrastructural damage were assessed with voxel-
based statistics. Associations between cognition, medial 
temporal lobe atrophy (MTA), lesion volumes, and global 
white matter ultrastructural damage indexed as increased 
mean diffusivity were tested with regression analysis 
by controlling for age. Diagnostic accuracy of imaging 
markers selected from a multivariate prediction model 
was tested with receiver operating characteristic analysis.
Results: Cognitively impaired patients (n = 53 [49.1%], classified 
as having probable vascular cognitive disorder) were older 
than nonimpaired patients (P = .027) and had more fre-
quent MTA (P , .001), more cortical infarctions (P = .016), 
and larger volumes of acute (P = .028) and chronic (P = 
.009) subcortical ischemic lesions. Lesion volumes did not 
correlate with global cognitive performance (lacunar infarc-
tions, P = .060; acute lesions, P = .088; chronic subcortical 
ischemic lesions, P = .085). In contrast, cognitive perfor-
mance correlated with presence of chronic ischemic lesions 
within the interhemispheric tracts and thalamic radiation 
(P , .05, false discovery rate corrected). Skeleton mean 
diffusivity showed the closest correlation with cognition 
(R2 = 0.311, P , .001) and promising diagnostic accuracy 
for vascular cognitive disorder (area under the curve, 0.82 
[95% confidence interval: 0.75, 0.90]). Findings were con-
firmed in subjects with a low risk of preclinical Alzheimer 
disease indexed by the absence of MTA (n = 85).
Conclusion: Subcortical white matter ischemic lesion locations and se-
verity of ultrastructural tract damage contribute to cogni-
tive impairment in symptomatic CAD, which suggests that 
subcortical disconnection within large-scale cognitive neural 
networks is a key mechanism of vascular cognitive disorder.
Published under a CC BY-NC-ND 4.0 license.
Online supplemental material is available for this article.
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Patients with symptomatic carotid 
artery disease (CAD) have an increased 
risk of developing vascular cognitive dis-
order (12) as a result of several mech-
anisms, including direct risks of emboli 
and hypoperfusion via shared risk fac-
tors, brain tissue injury resulting from 
small-vessel disease, and arterial stiff-
ness (4), in addition to being prone to 
age-related neurodegeneration. Elderly 
patients with symptomatic CAD are 
thus a particularly interesting group in 
which to assess the value of neuroim-
aging markers because of their height-
ened risk for multiple mechanisms.
We aimed to investigate the role 
of vascular tissue damage for global 
cognition and fluency, as this domain 
is believed to be impaired early in vas-
cular cognitive disorder (13). We hy-
pothesized that strategic lesion location 
and tissue damage severity are better 
indexes of vascular cognitive disorder 
than is lesion volume. To explore the 
role of putative commixed pathologic 
processes in our elderly cohort, we 
of amyloid pathologic abnormalities by 
using positron emission tomographic 
(PET) imaging (5) or cerebrospinal fluid 
biomarkers (6) cannot be used in clin-
ical practice, as these techniques are 
prohibitively expensive and moderately 
invasive. There is a need for imaging 
biomarkers that can be used to predict 
and track vascular cognitive disorder. 
Moreover, neuroimaging markers may 
afford mechanistic insights into the key 
processes that underlie vascular cogni-
tive disorder.
Several imaging studies yielded only 
a modest association between visible 
ischemic lesion burden and cognitive 
impairment, which is thought to be an 
underestimation of the effect of ische-
mia on cognition, as measurement of 
lesion burden fails to take ultrastruc-
tural tissue damage into account (7,8). 
Although the initial ischemic damage 
is focal, there is recognition of struc-
tural and functional alteration of distant 
brain regions due to the remote effects 
of lesions mainly reflecting Wallerian 
and transsynaptic degeneration (9).
White matter ultrastructural dam-
age can be quantified with diffusion-
tensor imaging (DTI), which allows the 
study of interrelations between the full 
extent of vascular tissue damage be-
yond visible lesions and cognitive im-
pairment. Two DTI metrics, fractional 
anisotropy (FA) and mean diffusiv-
ity, were shown to be correlated with 
myelin content and axonal loss (10). 
Furthermore, FA and mean diffusivity 
maps can be subjected to whole-brain 
voxel-based or tract-based analysis to 
overcome the recognized limitations of 
region of interest analysis (11).
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Advances in Knowledge
 n In patients with carotid artery 
disease, cerebrovascular lesion 
location in the thalamic radiation 
and interhemispheric fiber tracts 
contributes to global cognitive 
deficits, and lesions in the tha-
lamic radiation and long associa-
tion fibers affect fluency 
performance.
 n Severity of subcortical tissue 
damage, preferentially in major 
white matter tracts, contributes 
to global cognitive impairment 
(R2 = 0.311, P , .001), with skel-
eton mean diffusivity as the best-
performing imaging marker for 
the prediction of probable vascu-
lar cognitive disorder (area 
under the receiver operating 
characteristic curve, 0.82 [95% 
confidence interval: 0.75, 0.90]).
 n Findings were confirmed in 
patients with low risk of comor-
bid Alzheimer disease (absence 
of medial temporal lobe atrophy 
[MTA]), while presence of MTA 
was associated with more severe 
cognitive impairment, increased 
vascular lesion load, and more 
severe tissue damage.
 n Disconnection of large-scale cog-
nitive neural networks from cu-
mulative lesional and nonlesional 
tract injuries is proposed as a 
mechanism of cognitive impair-
ment in advanced 
arteriosclerosis.
Implication for Patient Care
 n The findings provide insights into 
how cerebrovascular disease con-
tributes to cognitive impairment 
and/or dementia and highlight 
the need to combat progressive 
subcortical brain tissue damage; 
average white matter skeleton 
mean diffusivity shows potential 
as a simple diagnostic marker of 
subcortical disconnection under-
lying vascular cognitive disorder.
The prevalence of vascular cog-nitive impairment and vascular dementia, which can be summa-
rized as vascular cognitive disorder (1), 
is increasing in the elderly (2). Diagnos-
ing vascular cognitive disorder remains 
challenging, and up to 44% of patients 
have coincident vascular and Alzheimer 
disease pathologic processes (3). New 
diagnostic criteria have been proposed 
to classify the disease as being probable 
or possible vascular cognitive disorder 
(4). To date, no useful imaging bio-
markers have been identified for vas-
cular cognitive disorder, and exclusion 
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selective T1-weighted three-dimension-
al gradient-echo sequence (repetition 
time msec/echo time msec, 8.8/4.11; 
inversion time, 570 msec; field of view, 
92 3 162; matrix, 384 3 384; and 102 
sections of 0.9-mm thickness acquired, 
covering the hippocampal formation 
fully in 50 cases).
Preprocessing of DTI data sets and 
computation of FA and mean diffusiv-
ity maps were performed by using the 
diffusion toolbox of FSL (Oxford Cen-
tre for Functional Magnetic Resonance 
Imaging of the Brain [FMRIB] Software 
Library, Oxford, England) (15). Isotro-
pic maximum diffusion images with a 
b value of 1000 sec/mm2 extracted from 
DTI images and mean diffusivity maps 
were used to outline acute ischemic 
lesions.
MTA Assessment
MTA was rated per subject on recon-
structed coronal FLAIR images by us-
ing the Scheltens scale (16) (D.M., 
with 6 years of neuroimaging training; 
and Q.S., a neurology trainee with a 
master of science in translational neu-
roimaging; supervised by D.P.A., with 
more than 25 years of quantitative neu-
roimaging research experience). Visual 
rating for all subjects was performed 
twice to study intrarater reliability. To 
validate the reliability of using recon-
structed FLAIR images to assess MTA, 
the Scheltens scale was also applied 
to all subjects who had coronal T1-
weighted images sufficiently covering 
the hippocampal formation (n = 50, 
D.M.). Assessments were performed 
while blinded to the patients’ age and 
clinical information. Presence of MTA 
was defined by using the following age 
range–specific cutoffs for the mean 
MTA scores (the averaged value of both 
hemispheres): MTA of more than 1.5 
in patients younger than 75 years of 
age, MTA of more than 2 in patients 
at least 75 years of age, and MTA of 
more than 2.5 in patients at least 85 
years of age (17). To validate the re-
liability of MTA assessment, intermo-
dality agreement (n = 50), interrater 
agreement (n = 108), and intrarater 
agreement (n = 108) were analyzed. 
Patients were further classified into 
were categorized as being cognitively 
intact or impaired on the basis of a 
cutoff value of 82, according to proven 
good sensitivity and specificity for de-
fining cognitive impairment (14). Nor-
mal daily functioning could be normal 
or mildly impaired, independent of 
the presence of motor and/or sensory 
symptoms.
In the cognitively impaired sub-
group, we further excluded subjects in 
whom a nonvascular cause of cognitive 
disorder was considered clinically. Ac-
cording to published diagnostic criteria 
(4), the following criteria for proba-
ble vascular cognitive disorder had to 
be met: (a) cognitive impairment (de-
fined in our study as ACE-R score , 
82), (b) imaging evidence of cerebro-
vascular disease (defined in our study 
as a chronic or acute ischemic lesion 
at fluid-attenuated inversion-recovery 
[FLAIR] imaging or diffusion-weighted 
imaging), (c) clear temporal relation-
ship between cerebrovascular disease 
and cognitive impairment, (d) no evi-
dence of another neurodegenerative 
disorder that may affect cognition 
before the onset of cerebrovascular 
disease, and (e) no history of gradually 
progressive cognitive impairment be-
fore or after manifestation of the cere-
brovascular disease. Criteria b–e were 
assessed clinically (by A.A.H., with 9 
years of clinical experience).
Image Acquisition
All MR images were acquired with a 3.0-
T imaging unit (Achieva; Philips Medi-
cal Systems, Best, the Netherlands). 
The imaging protocol included axial DTI 
(spin-echo single-shot diffusion-weight-
ed echo-planar imaging with a b value 
[gradient factor] of 1000 sec/mm2, 15 
directions, one volume with a b value 
of 0 sec/mm2 acquired, repetition time 
[sec]/echo time [msec] of 4.2/57, field 
of view of 224 3 224, matrix of 112 3 
112, and 45 sections of 3-mm thick-
ness acquired), axial FLAIR imaging 
(repetition time [sec]/echo time [sec] 
of 10.5/0.14; inversion time, 2.75 sec-
onds; field of view, 224 3 192; matrix, 
224 3 181; and 45 sections of 3-mm 
thickness acquired), and a plaque hem-
orrhage–sensitive, blood-nulled, water- 
assessed whether imaging and cognitive 
associations were similar in the sub-
group of patients at low risk for preclin-
ical Alzheimer disease—namely, those 
without medial temporal lobe atrophy 
(MTA). Second, we examined whether 
presence of MTA affected the vascular 
lesion load and nonlesional tissue dam-
age and used a multivariate prediction 
model of cognitive disorder to assess 
the independent contributions of vascu-
lar damage and MTA.
Materials and Methods
Subjects
The study protocol was approved by 
the ethics committee, and all partici-
pants gave written informed consent 
to undergo brain magnetic resonance 
(MR) imaging and the Addenbrooke’s 
Cognitive Examination–Revised (ACE-
R). Participants were recruited from 
a CAD imaging study that will be re-
ported elsewhere. From 2010 to 2015, 
subjects were recruited for the CAD 
imaging study (by A.A.H. and R.J.S.) 
if they experienced a recent nondis-
abling cerebrovascular event (stroke, 
transient ischemic attack, or amaurosis 
fugax) and were found to have ipsilat-
eral carotid arterial stenosis of more 
than 30%. Exclusion criteria were con-
traindications to MR imaging, language 
or sensory difficulties that would in-
terfere with cognitive assessment, and 
pre-existing cognitive impairment with 
possible causes other than vascular 
events. Research investigators (A.A.H. 
and R.J.S.) reviewed the clinical notes, 
spoke to all participants, and excluded 
(a) patients without the capacity to 
consent and (b) those with clinically ap-
parent or documented dementia before 
enrollment.
Cognitive Assessment and Criteria of 
Possible and Probable Vascular Cognitive 
Disorder
One hundred forty-seven CAD imaging 
study participants agreed to undergo 
cognitive assessments by using the 
ACE-R (14), which was conducted by 
trained researchers (A.A.H., R.J.S.) 
on the day of MR imaging. Participants 
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of hippocampal atrophy, we repeated 
all imaging analysis in the subgroup of 
patients without MTA.
Statistical Analysis
The spatial distribution of two kinds 
of lesion maps was compared on a 
voxel-by-voxel basis by using a Fisher 
test (with the false discovery rate con-
trolled at 0.05) as implemented in the 
NeuRoi software package (http://www.
nottingham.ac.uk/research/groups/
clinicalneurology/neuroi.aspx).
Reliability and agreement analysis.—
The inter- and intrarater reliability and 
the agreement of MTA measurement on 
reconstructed FLAIR images with that 
on coronal three-dimensional T1-weight-
ed gradient-echo images were assessed 
by using the Cohen k coefficient.
VLSM analysis.—Nonparametric 
mapping was used to relate lesion loca-
tion and cognitive performance (t test). 
Voxels affected in fewer than four sub-
jects (the default setting in VLSM) 
were not considered for analysis. False 
discovery rate was used to correct for 
multiple comparisons.
TBSS analysis.—The voxelwise sta-
tistical analysis of the DTI data was 
based on a nonparametric method by 
using a permutation test (n = 5000) with 
a general linear-model design matrix 
(25).
Tissue damage severity.—The age-
independent interrelations between se-
verity of tissue damage and cognition 
were assessed by using SPSS version 
21 software (SPSS, Chicago, Ill). The 
correlation coefficients were compared 
by using VassarStats software (http://
www.vassarstats.net/index.html).
Prediction models.—Univariate re-
gression analysis was first performed to 
initially explore the predictive value of 
age and various imaging markers, in-
cluding normalized volumes of lacunar 
infarctions, acute and chronic ischemic 
lesions, mean diffusivity values of in-
farctions, chronic subcortical ischemic 
lesions, NAWM and WMT skeleton, 
and MTA for cognitive status. Given the 
number of cognitively impaired subjects 
(n = 53), five factors were selected for 
creating the multivariate prediction 
model.
The total ischemic lesion load was 
calculated by adding the normalized 
volumes of nonoverlapping acute and 
chronic lesions and was logarithmically 
expressed to account for nonnormal 
distribution.
Lesion Topography, White Matter Tract 
Topography, and Tissue Damage Severity
Since results of a previous study dem-
onstrated the strategic role of lacunar 
infarctions located at the hippocampus, 
thalamus, mesial temporal areas, basal 
forebrain, and frontocingular cortex in 
vascular dementia (21), the frequency 
of infarctions at these locations was 
recorded.
Voxel-based lesion-symptom map-
ping (VLSM) (http://www.neuroling.
arizona.edu/resources.html) was used 
to determine lesion locations associ-
ated with cognition and fluency (22). 
All analyses were controlled for age and 
total ischemic lesion load (logarithmi-
cally expressed). Additionally, perfor-
mance of memory, language, attention, 
and visuospatial ability derived from 
ACE-R was controlled for when assess-
ing the association between lesion lo-
cations and fluency. Significant voxels 
were projected onto the 1 3 1 3 1-mm 
MNI template, and major white matter 
tracts (WMTs) that contained signifi-
cant clusters were identified from the 
WMT atlas within FSL (23).
Whole white matter ultrastructural 
damage and its association with global 
cognition and fluency were investigated 
by means of tract-based spatial statis-
tics (TBSS) on FA and mean diffusivity 
maps. The standard TBSS procedure 
was applied to this study (24).
Mean diffusivity values were de-
rived from each individual’s maps of 
chronic subcortical ischemic lesions, 
normal-appearing white matter (NAWM), 
and WMT skeleton to investigate tissue-
specific injury. Infarction severity was 
not studied owing to the mixed type of 
infarctions, which may confound the as-
sessment of severity of tissue damage.
To confirm whether the imaging-
cognitive associations were indepen-
dent of potentially comorbid but pre-
clinical Alzheimer disease pathologic 
processes, as indexed by the presence 
two subgroups according to their MTA 
score: those with MTA and those with-
out. Patients without MTA who have 
clinically probable vascular cognitive 
disorder can be considered to have a 
low risk of having comorbid Alzheimer 
disease (18).
Lesion Mapping
FLAIR and diffusion images were reg-
istered into Montreal Neurological In-
stitute (MNI) template space by using 
FSL tools (19). Lacunar infarctions, 
acute ischemic infarctions, chronic 
subcortical ischemic lesions, and cor-
tical infarctions were separately and 
manually outlined (by D.M., a trained 
investigator) on coregistered images 
by using locally developed NeuRoi soft-
ware (http://www.nottingham.ac.uk/ 
research/groups/clinicalneurology/
neuroi.aspx). Lacunar infarctions were 
defined as small (,20-mm) hypoin-
tense subcortical areas on FLAIR im-
ages. Hyperintense lesions on images 
acquired with a b value of 1000 sec/
mm2 that were hypointense on mean 
diffusivity maps were considered acute 
ischemic infarctions. Subcortical FLAIR 
hyperintense lesions were considered 
to reflect chronic subcortical ischemic 
lesions, and cortical FLAIR hypoin-
tensities were considered to reflect 
chronic cortical infarctions. Then, three 
kinds of lesion maps were generated: 
(a) an “infarction frequency map” in-
cluded acute ischemic infarctions and 
chronic cortical and lacunar infarc-
tions, (b) a “chronic subcortical ische-
mia frequency map” was generated by 
adding chronic subcortical ischemic 
lesions, and (c) a “total ischemic lesion 
frequency map” was created by com-
bining both maps.
Lesion Burden
Lesion type–specific volumes were 
calculated by using NeuRoi software. 
FLAIR brain images without skull, ex-
tracted by using the “Brain Extraction 
Tool” of the Oxford Centre for Func-
tional Magnetic Resonance Imaging 
of the Brain (20), were loaded into 
NeuRoi for calculating total brain vol-
umes. Lesion volumes were divided by 
total brain volumes for normalization. 
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Three strategic thalamic lacunar 
infarctions were seen in cognitively 
impaired patients (5.6%), but none 
were seen in cognitively intact sub-
jects. Cognitively impaired subjects (n 
= 53, 49.1%) also showed qualitatively 
more extended patterns of the infarc-
tions (Fig 1a) and chronic subcortical 
ischemia frequencies (Fig 1b), but the 
difference was not significant by using 
voxel-based analysis (false discovery 
rate corrected, P . .05). Additionally, 
according to visual inspection, no in-
farctions or chronic subcortical ische-
mic lesions were located in the known 
language brain areas, such as superior 
and middle temporal gyri, inferior fron-
tal gyri, and insula, which may affect 
language performance (26).
Voxelwise group comparisons of mean 
diffusivity and/or FA maps demonstrated 
Neuroimaging Differences between 
Cognitively Impaired Patients and 
Unimpaired Patients
Cognitively impaired patients had 
larger normalized acute lesion vol-
umes (mean 6 standard deviation, 
[5.9 6 11.3] 3 1024 for cognitively 
impaired patients vs [2.7 6 5.1] 3 
1024 for cognitively intact patients; 
P = .028), higher chronic subcortical 
ischemic volumes ([15.5 6 15.5] 3 
1023 for cognitively impaired patients 
vs [8.0 6 10.5] 3 1023 for cognitively 
intact patients, P = .009), and more 
cortical infarctions (n = 4 [3.7%] cog-
nitively impaired patients; n = 0 [0%] 
cognitively intact patients; P = .016) 
after controlling for age (Table 2). 
Similar group differences were found 
in the subgroup without MTA (Table 
E1 [online]).
The area under the receiver oper-
ating characteristic curve for the di-
agnosis of probable vascular cognitive 
disorder was constructed by using SPSS 
software for the imaging metrics se-
lected from the prediction model.
A P value less than .05 was consid-
ered to indicate a significant difference 
for all analyses.
Results
Of the 147 participants, 38 had to be 
excluded owing to incomplete MR ex-
amination or poor quality of MR images 
as assessed visually, and one subject 
was excluded because of comorbid Par-
kinson disease that likely contributed 
to cognitive impairment. This resulted 
in a cohort of 108 subjects. Fifty-three 
patients (49.1%) were cognitively im-
paired and were classified as having 
probable vascular cognitive disorder. 
Forty-eight of these had experienced 
first-ever stroke without any known 
cognitive impairment or other relevant 
background. Four subjects had a pre-
vious history of poststroke cognitive 
impairment with subsequent partial im-
provement, and one subject later devel-
oped cerebral hemorrhage, which was 
considered to be amyloid angiopathy. 
Patients with abnormal cognition were 
older (P = .027), had a higher percent-
age of smokers (P = .015), and had 
more peripheral vascular disease (P = 
.017) than those with normal cognition 
(n = 55, 50.9%). Of the 108 subjects, 
98 subjects (90.7%) were not at risk 
for cerebral hemodynamic impairment 
due to carotid stenosis of less than 80% 
on either side or both sides (Table 1). 
Among 10 subjects who had carotid ste-
nosis of more than 80% on either side, 
three subjects had bilaterial carotid ste-
nosis of more than 80%.
MTA scores showed high inter- and 
intrarater reliability and similarly good 
agreement between assessment on FLAIR 
images and coronal T1-weighted images 
(Appendix E1 [online]). Twenty-three 
subjects (21.3%) had MTA, while 85 sub-
jects (78.7%) did not. Most subjects with 
MTA were cognitively impaired (n = 20, 
87.0%), compared with 33 (38.8%) of 
those without MTA (P , .001).
Table 1
Demographics, MR Imaging Characteristics, and Cognitive Profile of the Study Cohort 
and Comparison between Cognitive Subgroups
Characteristic
Patients with Normal  
Cognition (n = 55)
Patients with Abnormal  
Cognition (n = 53) P Value
Mean age (y)* 72.7 6 9.5 76.6 6 8.6 .027†
No. of women 22 (40.0) 20 (37.7) .845
Atrial fibrillation 10 (18.2) 14 (26.4) .359
Peripheral vascular disease 4 (7.3) 13 (24.5) .017†
Ischemic heart disease 16 (29.1) 18 (34.0) .680
Hypertension 44 (80.0) 44 (83.0) .806
Smoking 30 (54.5) 41 (77.4) .015†
Diabetes mellitus 12 (21.8) 12 (22.6) .918
Symptom (stroke) 23 (41.8) 30 (56.6) .178
Symptomatic side (left) 24 (43.6) 28 (52.8) .441
Ipsilateral degree of carotid stenosis .154
 30%–49% stenosis 29 (52.7) 21 (39.6)
 50%–69% stenosis 18 (32.7) 27 (50.9)
 .70% stenosis 8 (14.5) 5 (9.4) .820
 .80% stenosis‡ 4 (7.3) 3 (5.7) .734
Contralateral degree of carotid stenosis .179
 0%–29% stenosis 38 (69.1) 33 (62.3)
 30%–49% stenosis 9 (16.4) 4 (7.5)
 50%–69% stenosis 5 (9.1) 10 (18.9)
 .70% stenosis 3 (5.5) 6 (11.3) .254
 .80% stenosis‡ 2 (3.6) 4 (7.5) .375
Mean time from symptom onset to MR imaging (d)* 36.9 6 27.0 33.3 6 33.9 .519
Patients with MTA 3 (5.5) 20 (37.7) ,.001†
Note.—Numbers in parentheses are percentages.
* Data are means 6 standard deviations.
† Statistically significant (P , .05).
‡ Threshold for possible hemodynamic impairment . 80%—that is, subgroup of .70%. P value refers to .80% vs rest.
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widespread mean diffusivity increases 
and FA decreases between patients with 
abnormal cognition and those with nor-
mal cognition (Fig E1 [online]).
In cognitively impaired patients ver-
sus normal subjects, mean diffusivity 
(Table 3) was increased in chronic sub-
cortical ischemic lesions ([1.05 6 0.09] 
3 1029 m2/sec in cognitively impaired 
patients vs [0.99 6 0.11] 3 1029 m2/sec 
in normal patients [P = .007]; partial Ƞ2 
= 0.068 [95% confidence interval {CI}: 
0.016, 0.095), NAWM ([0.78 6 0.04] 
3 1029 m2/sec for cognitively impaired 
patients and [0.75 6 0.03] 3 1029 m2/
Figure 1: (a) Infarction maps in patients with normal cognition and those with abnormal cognition. Maps were superimposed onto the 1 3 1 3 1-mm MNI152 
standard-space T1-weighted average structural template. The color bars show the variation between the minimum and maximum number of lesions. Z score maps 
represent the result of group comparison between patients with normal cognition and those with abnormal cognition. The significant voxels (according to results of the 
Fisher test) did not survive the false discovery rate correction. The color bar of the Z score maps shows the variation in Z score between the minimum and maximum 
values. (b) Chronic subcortical ischemic lesion frequency maps in patients with normal cognition and those with abnormal cognition. Details are the same as for a.
Table 2
Lesion Volumes, MTA, and Cognition
Parameter
Patients with Normal  
Cognition (n = 55)
Patients with Abnormal  
Cognition (n = 53)
P Value † P Value‡
Correlation with  
Global Cognition
Correlation with  
Fluency
Without MTA  
(n = 52)
With MTA  
(n = 3)
Without MTA  
(n = 33)
With MTA  
(n = 20) P Value* R2 Value P Value § R2 Value P Value ||
Mean age (y)# 72.3 6 9.4 79.3 6 10.6 76.7 6 9.3 76.9 6 7.4 .887 .027** .150 … … … …
Mean ACE-R score# 89.9 6 4.2 86.6 6 3.2 73.7 6 6.9 71.4 6 9.3 .302 ,.001** .001** … … … …
No. of patients with lacunar  
infarctions
8 (15.4) 1 (33.3) 10 (30.3) 5 (25.0) .703 .241 .760 … … … …
Percentage normalized  
lacunar infarction  
volumes (31025)#
0.9 6 2.7 0.6 6 0.1 3.4 6 7.9 2.0 6 4.2 .449 .063 .899 0.03 .060 0.07 .005**
No. of patients with acute 
lesions
17 (32.7) 2 (66.7) 17 (51.5) 10 (50.0) .899 .050 .245 … … … …
Percentage normalized acute 
lesion volume (31024)#
2.3 6 4.8 7.9 6 7.6 6.0 6 11.3 5.7 6 11.6 .912 .028** .226 0.03 .088 0.03 .072
Percentage normalized  
chronic subcortical  
ischemic lesion  
volume (31023)#
7.9 6 10.7 9.1 6 9.2 14.1 6 15.5 17.7 6 15.6 .400 .009** .079 0.03 .085 0.07 .007**
No. of patients with  
cortical infarctions
0 (0) 0 (0) 2 (6.1) 2 (10.0) .623 .016** .112 … … … …
Note.—Numbers in parentheses are percentages.
* P value for the comparison between cognitively impaired patients with MTA and those without MTA, controlled for age.
† P value for the comparison between patients with normal cognition and those with abnormal cognition, controlled for age.
‡ P value for the comparison between patients with MTA and patients without MTA, controlled for age.
§ P value for the correlation between lesion volumes and global cognitive performance, controlled for age.
|| P value for the correlation between lesion volumes and fluency, controlled for age.
# Data are means 6 standard deviations.
** Statistically significant (P , .05).
sec for normal patients [P = .002]; Ƞ2 
= 0.086 [95% CI: 0.008, 0.037]), and 
WMT skeleton ([0.83 6 0.05] 3 1029 
m2/sec for cognitively impaired patients 
vs [0.77 6 0.03] 3 1029 m2/sec for 
normal patients [P , .001]; Ƞ2 = 0.271 
[95% CI: 0.035, 0.067]).
In patients without MTA (n = 85), 
both NAWM and WMT skeleton mean 
diffusivity were also significantly higher 
in cognitively impaired patients versus 
normal patients (NAWM, P = .047 [Ƞ2 
= 0.047; 95% CI: 0.001, 0.028]; WMT 
skeleton, P , .001 [Ƞ2 = 0.230; 95% CI: 
0.024, 0.057]) (Table E2 [online]).
Neuroimaging Findings and Cognitive 
Impairment: Correlation Analyses
None of the normalized lesion type vol-
umes were significantly correlated with 
global cognition (lacunar infarctions, 
P = .060; acute lesions, P = .088; 
chronic subcortical ischemic lesions, P 
= .085). In contrast, normalized lacu-
nar infarction volumes (R2 = 0.07, P = 
.005) and chronic subcortical ischemic 
lesion volumes (R2 = 0.07, P = .007) 
were negatively correlated with fluency 
performance (Table 2). Interestingly, in 
patients without MTA, normalized lacu-
nar infarction volumes were correlated 
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between global cognition and chronic 
subcortical ischemic lesion mean diffu-
sivity (P = .018) or NAWM mean diffu-
sivity (P = .004).
Predictive Value and Diagnostic Accuracy 
of Imaging Measures
On the basis of univariate regression 
analyses, normalized volume of chronic 
subcortical ischemic lesions (P = .007), 
mean diffusivity of chronic subcortical 
ischemic lesions (P = .004), NAWM 
(P = .001), WMT skeleton (P , .001), 
and MTA (P , .001) were found to be 
predictors of cognitive status. After en-
tering these factors into the multivar-
iate prediction model, WMT skeleton 
mean diffusivity (P = .001, exp[b] = 
38.880 [95% CI: 4.207, 359.336]) and 
MTA score (P = .015, exp[b] = 6.074 
[95% CI: 1.426, 25.867]) remained as 
the only independent significant factors 
(Table E3 [online]).
The receiver operating characteris-
tic curves of WMT skeleton mean diffu-
sivity and MTA score for the diagnosis 
of cognitive deficits were constructed 
separately (Fig 5), with an area under 
the receiver operating characteristic 
curve of 0.82 (95% CI: 0.75, 0.90) for 
global cognition was widespread on 
the basis of TBSS (Table 4; Fig 3, A). A 
similar correlation pattern was identi-
fied between fluency and mean diffusiv-
ity of widespread white matter except 
forceps major and right inferior longi-
tudinal fasciculus (Table 4; Fig 3, B). 
The analyses of correlation between 
FA and global cognition yielded similar 
results (Fig E3 [online]). No significant 
correlation was identified between 
FA and fluency. The pattern of wide-
spread WMT damage associated with 
impaired cognition in the subgroup of 
patients without MTA was similar to 
that in the whole study cohort (Fig 
E4 [online]). We found a consistent, 
indirect interrelation between tissue-
specific mean diffusivity and cognitive 
performance after controlling for age 
(chronic subcortical ischemic lesions, 
R2 = 0.090 [P = .002]; NAWM, R2 = 
0.074 [P = .005]; WMT skeleton, R2 
= 0.311 [P , .001]) (Table 3, Fig 4). 
Similar interrelations were also identi-
fied in patients without MTA (n = 85) 
(Table E2 [online]). Also, the partial 
correlation between global cognition 
and WMT skeleton mean diffusivity 
was significantly stronger than that 
with both global cognition (R2 = 0.06, 
P = .030) and fluency (R2 = 0.08, P = 
.007), while normalized acute lesion 
volumes were correlated with global 
cognition (R2 = 0.06, P = .020) but not 
fluency (Table E1 [online]).
Significant correlations were identi-
fied between clusters of chronic subcor-
tical ischemia presence and global cog-
nition and fluency (false discovery rate, 
q = 0.05; threshold, t = 2.4) by using 
VLSM. A total of 159 and 1351 voxels 
were identified in which presence of 
chronic subcortical ischemia was signif-
icantly related to impaired global cogni-
tion and fluency, respectively. Clusters 
for global cognition were mainly pro-
jected onto the anterior thalamic radia-
tion, forceps minor, and forceps major 
(Table 4; Fig 2, A). Clusters for fluency 
were mainly projected onto the ante-
rior thalamic radiation and superior 
longitudinal fasciculus (Table 4; Fig 2, 
B). No significant clusters were identi-
fied for the infarction frequency maps 
and global cognition or fluency. Similar 
results were identified in patients with-
out MTA (n = 85, Fig E2 [online]).
Age-independent correlation be-
tween WMT mean diffusivity and 
Table 3
Severity of Tissue Damage and Cognitive Performance
Parameter
Normal Cognition (n = 55) Abnormal Cognition (n = 53)
P Value † P Value ‡
Correlation with  
Global Cognition
Correlation with  
Fluency
Without MTA  
(n = 52)
With MTA  
(n = 3)
Without MTA  
(n = 33)
With MTA  
(n = 20) P Value * R 2 Value P Value § R2 Value P Value ||
Chronic subcortical 
ischemic lesion  
mean diffusivity  
(31029 m2/sec)
0.99 6 0.11 1.00 6 0.06 1.03 6 0.09 1.07 6 0.09 .137 .007# .032# 0.090 .002# 0.045 .029#
NAWM mean diffusivity 
(31029 m2/sec)
0.75 6 0.03 0.76 6 0.04 0.77 6 0.04 0.80 6 0.05 .028# .002# .003# 0.074 .005# 0.028 .085
WMT skeleton mean 
diffusivity  
(31029 m2/sec)
0.78 6 0.03 0.80 6 0.04 0.83 6 0.05 0.86 6 0.06 .015# ,.001# ,.001# 0.311 ,.001# 0.191 ,.001#
Note.—Data are means 6 standard deviations, unless indicated otherwise.
* P value for the comparison between cognitively impaired patients with MTA and those without MTA, controlled for age.
† P value for the comparison between patients with normal cognition and those with abnormal cognition, controlled for age.
‡ P value for the comparison between patients with MTA and patients without MTA, controlled for age.
§ P value for the age-independent correlation between mean diffusivity of chronic subcortical ischemic lesions, NAWM, WMT skeleton, and global cognitive performance.
|| P value for the age-independent correlation between mean diffusivity of chronic subcortical ischemic lesions, NAWM, WMT skeleton, and global cognitive performance in subjects without MTA.
# Statistically significant (P , .05).
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damage, indexed according to mean diffu-
sivity increase, were associated with cog-
nitive impairment. These results suggest 
that subcortical disconnection of large-
scale cognitive neural networks that re-
sult from strategic and cumulative lesional 
and nonlesional tract damage play a key 
role in cognitive impairment in advanced 
arteriosclerosis.
Discussion
In this multimodal MR imaging study in 
108 patients with advanced arterioscle-
rosis and a recent cerebrovascular event, 
we found that the location of chronic sub-
cortical ischemic lesions in the anterior 
thalamic radiation and interhemispheric 
fiber tracts and the severity of WMT 
WMT skeleton mean diffusivity and an 
area under the curve of 0.66 (95% CI: 
0.56, 0.77) for MTA score. At a mean 
diffusivity cutoff value of 0.797 3 1029 
m2/sec, sensitivity and specificity were 
77.4% and 72.7%, respectively. At 
a cutoff value of 0.75 for mean MTA 
score, sensitivity was 72.2%, and spec-
ificity was 55.5%.
Table 4
MNI Coordinates for the Local Maxima of Clusters That Correlate with Cognition
Analysis Type and Location Cluster Size (voxels)
MNI Coordinates of Peak  
Voxel (mm)
T Value
P Value  
(family-wise 
error corrected)X Y Z
VLSM results: cluster showing significant correlation between chronic  
subcortical ischemic lesion location and global cognitive performance
 Left anterior thalamic radiation 18 222 36 2 3.12 …
 Forceps minor 12 218 32 8 3.59 …
 Forceps major (left) 18 228 265 7 2.56 …
 Forceps major (right) 11 26 271 16 2.40 …
VLSM results: cluster showing significant correlation between chronic  
subcortical ischemic lesion location and fluency
 Left anterior thalamic radiation 1243 226 15 22 4.32 …
 Left superior longitudinal fasciculus 33 227 17 16 2.94 …
 Right anterior thalamic radiation 9 31 39 6 2.72 …
TBSS results: cluster showing significant correlation between mean  
diffusivity and global cognitive performance
 Forceps major 4247 22 239 12 … .016
 Forceps minor 4706 211 24 15 … .017
 Left anterior thalamic radiation 5977 222 14 13 … .015
 Right anterior thalamic radiation 3713 31 24 13 … .012
 Left inferior fronto-occipital fasciculus 7238 229 22 38 … .016
 Right inferior fronto-occipital fasciculus 4446 32 259 11 … .022
 Left inferior longitudinal fasciculus 4822 239 249 11 … .017
 Right inferior longitudinal fasciculus 2256 30 267 12 … .025
 Left superior longitudinal fasciculus 7029 221 220 41 … .016
 Right superior longitudinal fasciculus 2510 212 217 30 … .025
 Fornix 1112 0 24 14 … .023
 Left cingulum 2007 218 237 30 … .016
 Right cingulum 655 220 4 28 … .022
TBSS results: cluster showing significant correlation between mean  
diffusivity and fluency
 Forceps minor 4160 219 6 14 … .033
 Left anterior thalamic radiation 3924 220 6 15 … .025
 Right anterior thalamic radiation 2796 7 228 23 … .034
 Left inferior fronto-occipital fasciculus 4296 223 10 17 … .027
 Right inferior fronto-occipital fasciculus 2577 13 55 28 … .035
 Left inferior longitudinal fasciculus 1955 229 22 38 … .033
 Left superior longitudinal fasciculus 4182 221 5 17 … .028
 Right superior longitudinal fasciculus 396 218 225 51 … .037
 Fornix 196 7 229 23 … .027
 Left cingulum 1077 219 44 17 … .033
 Right cingulum 364 17 235 30 … .033
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Figure 2
Figure 2: A, Maps show the topography of 
chronic ischemic lesions associated with global 
cognitive impairment. Significant clusters (red) ac-
cording to VLSM analysis (P , .05, false discovery 
rate corrected, controlled for age and normalized 
total ischemic lesion volumes after logarithmic 
transformation) are projected onto the MNI152 
standard-space T1-weighted average structural 
template image with overlain selected WMTs from 
the Johns Hopkins University DTI-based white 
matter atlas (yellow, forceps major; brown, anterior 
thalamic radiation; blue, forceps minor). B, Maps 
show the topography of chronic ischemic lesions 
associated with impaired fluency. Details are the 
same as for A (green, superior longitudinal fascicu-
lus). L = left, R = right.
Our findings confirm and extend 
the strategic role of anterior thalamic 
radiation and interhemispheric fiber 
damages as a mechanism of cogni-
tive impairment, as previously shown 
in small-vessel disease (27) and in 
manifest vascular disease due to arte-
riosclerosis anywhere (28). The identi-
fication of anterior thalamic radiation 
and superior longitudinal fasciculus 
as strategic WMTs for fluency in our 
study also closely replicates results in 
manifest vascular disease (28). The 
consistency of findings across different 
patient cohorts highlights that lesion 
location rather than disease origin de-
termines cognitive outcomes. This in 
turn is concordant with our current 
understanding that disconnection of 
large-scale cognitive networks through 
the anterior thalamic radiation and the 
forceps minor underlies vascular cogni-
tive disorder in both small- and large-
artery disease. In contrast to previous 
studies in vascular disease, we found a 
key role of the forceps major in global 
cognition (27,28). This partial discrep-
ancy could be due to the differences 
in the underlying vasculopathy but is 
more likely due to variation in cogni-
tive assessments. In previous studies, 
investigators focused on processing 
speed or executive function, which 
mainly reflect frontal lobe dysfunc-
tions (27,28). Forceps major integrity, 
on the other hand, has been related 
to memory, attention, and executive 
functions (29). Interestingly, the global 
cognitive role of the forceps major in 
nonvascular brain diseases, such as 
multiple sclerosis (30,31), suggests 
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further contribute to the recognized 
increasing prevalence of mixed path-
ologic findings in the elderly (3). Fu-
ture research is needed to confirm 
and further characterize such interac-
tions and putative responsiveness to 
therapeutic interventions. This will be 
facilitated by the combined use of two 
simple imaging measures from stan-
dard brain MR imaging examinations: 
MTA as an established marker of hip-
pocampal pathologic abnormalities 
and WMT skeleton mean diffusivity, 
which we propose as a new, promis-
ing marker of subcortical disconnec-
tion. WMT skeleton mean diffusivity 
also has potential as an imaging bio-
marker of vascular cognitive disorder 
(area under the receiver operating 
characteristic curve, 0.82; sensitiv-
ity, 77.4%; specificity, 72.7%). The 
lower specificity compared with cere-
brospinal fluid biomarkers (sensitivity, 
of cerebrovascular lesion burden than 
lesions visible on MR images do. This is 
corroborated by the finding that lesion 
volumes played no role or only a minor 
role in explaining global cognitive and 
fluency performance, which is well in 
line with previous reports (7,36). Taken 
together, topographic, volumetric, and 
diffusivity findings converge and point 
to a key role of subcortical disconnec-
tion within large-scale cognitive neural 
networks that may underpin vascular 
cognitive disorder.
It is noteworthy that cognitively 
impaired subjects with MTA showed 
more extensive ultrastructural white 
matter damage than those without 
MTA, even after age correction (Table 
3). While speculative, this association 
would be consistent with the notion 
of supra-additive cognitive effects of 
vascular and neurodegenerative path-
ologic processes (37,38) that may 
that consistent structural-cognitive in-
terrelations exist in disconnection dis-
orders across different diseases.
The observed widespread age-in-
dependent associations between ultra-
structural white matter damage and 
global cognition, as well as fluency, 
agree well with the results of previ-
ous studies in patients with subcorti-
cal vascular dementia (32), cerebral 
autosomal-dominant arteriopathy with 
subcortical infarcts and leukoencepha-
lopathy (33), and mild cognitive im-
pairment (34). Diffusional changes are 
thought to reflect primary or secondary 
tissue damage, including Wallerian de-
generation with myelin damage, axonal 
loss, gliosis, and incomplete ischemia 
(35,36). We thus consider that the 
observed WMT ultrastructural dam-
age reflects cumulative focal and re-
mote effects of vascular tissue damage, 
thereby providing a more reliable index 
Figure 3
Figure 3: A, Maps show WMT mean diffusivity and global cognition. Significant TBSS results show skeletal voxels (red) where increased mean diffusivity correlated 
with global cognitive decline (controlled for age and normalized total ischemic lesion volumes after logarithmic transformation, P , .05, corrected). Mean TBSS tract 
skeleton (green) and total ischemic lesion distribution map (yellow) were overlaid on the MNI152 standard-space T1-weighted average structural template image. B, 
Maps show WMT mean diffusivity and fluency. Details are the same as for A. L = left, R = right.
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to MR imaging. This is, however, un-
likely to have biased our results, as we 
did not observe cognitive associations 
with acute infarction metrics. Last, 
in this study, we did not investigate 
the presence of hemodynamic impair-
ment and hence cannot exclude this 
as a contributory factor in individual 
subjects. Nevertheless, only 10 of 108 
subjects (9.3%) had more than 80% 
carotid arterial stenosis, and only a 
subgroup of these can be expected to 
show hemodynamic impairment.
In conclusion, we demonstrated 
that lesional and ultrastructural affec-
tion of the WMT skeleton contributes 
to cognitive impairment in patients with 
recently symptomatic CAD, indepen-
dent of the effect of age, and also in pa-
tients without MTA. This supports the 
notion that subcortical disconnection 
our cohort were considered to have 
probable vascular cognitive disorder. 
Nevertheless, we cannot exclude pre-
morbid Alzheimer disease, with an 
expected prevalence of 11%–20% in 
those aged 65 and older (40,41). In 
the absence of amyloid PET data, we 
used the indirect marker of MTA with 
proven high positive and negative pre-
dictive value for Alzheimer disease 
(17,18). We found that just over 21% 
of our cohort showed MTA. Impor-
tantly, all main findings reported in 
the whole study group were confirmed 
in the subgroup of subjects without 
MTA, considered to be at low risk of 
Alzheimer disease. This allows us to 
largely exclude a confounding effect 
from undetected Alzheimer disease. 
Second, we have a variable time in-
terval from the cerebrovascular event 
68%; specificity, 87%) (39) could be 
explained by the milder end of the cog-
nitive deficit profile in our study.
The main limitations of our study 
are a lack of neuropsychometric infor-
mation on premorbid cognition due to 
the study design and a lack of direct 
diagnostic tools for amyloid pathologic 
abnormalities. We are, however, con-
fident that we excluded patients with 
premorbid dementia, as a research 
investigator with up to 9 years of clin-
ical experiences (A.A.H.) spoke to all 
participants and carefully reviewed 
clinical notes to exclude patients with-
out the capacity to consent and those 
with clinically apparent dementia be-
fore MR imaging examination. Also, 
on the basis of the clinical information 
and the published diagnostic criteria, 
all 53 cognitively impaired subjects in 
Figure 4
Figure 4: Scatterplots show the correlation between mean 
diffusivity (MD) within chronic subcortical ischemic lesions, 
NAWM, WMT skeleton, and global cognitive performance, 
corrected for age.
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of cognitive neural networks is a key 
mechanism of cognitive impairment in 
patients with probable vascular cogni-
tive disorder.
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